Morgan Stanley’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$58.6M Buy
1,247,783
+352,208
+39% +$16.6M ﹤0.01% 1779
2025
Q1
$39.5M Sell
895,575
-1,101,701
-55% -$48.6M ﹤0.01% 2029
2024
Q4
$72.2M Buy
1,997,276
+558,641
+39% +$20.2M 0.01% 1505
2024
Q3
$46.1M Buy
1,438,635
+1,112,516
+341% +$35.6M ﹤0.01% 1900
2024
Q2
$12.3M Sell
326,119
-254,943
-44% -$9.6M ﹤0.01% 3153
2024
Q1
$28.6M Sell
581,062
-560,266
-49% -$27.6M ﹤0.01% 2299
2023
Q4
$41.7M Buy
1,141,328
+613,366
+116% +$22.4M ﹤0.01% 2647
2023
Q3
$12.2M Buy
527,962
+187,088
+55% +$4.33M ﹤0.01% 2932
2023
Q2
$8.94M Buy
340,874
+12,969
+4% +$340K ﹤0.01% 3272
2023
Q1
$8.44M Sell
327,905
-41,781
-11% -$1.08M ﹤0.01% 3301
2022
Q4
$9.62M Sell
369,686
-385,931
-51% -$10M ﹤0.01% 3134
2022
Q3
$21.6M Buy
755,617
+257,965
+52% +$7.36M ﹤0.01% 2110
2022
Q2
$12.3M Buy
497,652
+347,754
+232% +$8.56M ﹤0.01% 2853
2022
Q1
$8.46M Buy
149,898
+61,623
+70% +$3.48M ﹤0.01% 3103
2021
Q4
$5.47M Sell
88,275
-24,961
-22% -$1.55M ﹤0.01% 3629
2021
Q3
$7.18M Buy
113,236
+32,035
+39% +$2.03M ﹤0.01% 3304
2021
Q2
$6.69M Sell
81,201
-52,665
-39% -$4.34M ﹤0.01% 3462
2021
Q1
$9.85M Buy
133,866
+60,696
+83% +$4.47M ﹤0.01% 2673
2020
Q4
$5.31M Buy
73,170
+63,039
+622% +$4.57M ﹤0.01% 3194
2020
Q3
$483K Sell
10,131
-6,733
-40% -$321K ﹤0.01% 4664
2020
Q2
$708K Buy
16,864
+15,807
+1,495% +$664K ﹤0.01% 4408
2020
Q1
$29K Sell
1,057
-14,420
-93% -$396K ﹤0.01% 5679
2019
Q4
$595K Buy
15,477
+9,045
+141% +$348K ﹤0.01% 4832
2019
Q3
$139K Buy
+6,432
New +$139K ﹤0.01% 5314